Recent News for EVLO - Evelo Biosciences, Inc.

Date Title
Apr 12 Mid-Afternoon Market Update: Dow Falls Over 100 Points; Canaan Shares Tumble After Q4 Results
Apr 12 Twist Bioscience and Codexis in focus as Piper Sandler upbeat on synthetic biology, and more in today’s analyst action
Apr 5 Evelo Biosciences to Present at 20th Annual Needham Virtual Healthcare Conference
Mar 30 Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer
Mar 23 The Daily Biotech Pulse: FDA Approvals For Merck, Pacira And Zealand, Roche-Regeneron Ace Late-Stage COVID-19 Study, AlloVir Appoints Gilead Virology Chief As CEO
Mar 23 Evelo Bio inks EDP1815 development deal for inflammatory diseases & COVID-19
Mar 23 Evelo Biosciences & Abdul Latif Jameel Health Announce Strategic Collaboration to Develop & Commercialize Novel Therapy EDP1815 for Inflammatory Diseases & COVID-19 in Select Developing Markets Serving 1.7 Billion People
Mar 9 Evelo Biosciences, Inc. (EVLO) Q4 2020 Earnings Call Transcript
Mar 9 Evelo Biosciences, Inc. (EVLO) CEO Balkrishan Gill on Q4 2020 Results - Earnings Call Transcript
Mar 9 Evelo Biosciences, Inc. 2020 Q4 - Results - Earnings Call Presentation
Mar 9 Evelo Biosciences EPS misses by $0.09
Mar 9 Evelo Biosciences Announces Fourth Quarter and Full Year 2020 Financial Results and Business Highlights
Mar 9 Earnings Scheduled For March 9, 2021
Mar 6 The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Mar 2 Evelo Biosciences to Report Fourth Quarter and Full Year 2020 Financial Results on Tuesday, March 9, 2021
Feb 16 Evelo Biosciences Appoints John A. Hohneker, M.D. to Board of Directors
Feb 6 Notable Insider Buys Of The Past Week: Harley-Davidson, Texas Instruments And More
Feb 1 88 Biggest Movers From Friday
Jan 29 Evelo Bio secures ~$67.5M capital raise
Jan 29 Evelo Biosciences Announces Pricing of Public Offering of Common Stock
Jan 28 Evelo announces plans of $50M capital raise
Jan 28 Evelo Biosciences Announces Proposed Public Offering of Common Stock
Jan 21 The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping
Jan 20 Evelo surges after announcing positive confirmatory data from a trial for dermatitis
Jan 20 Evelo Biosciences Reports New Positive Confirmatory Data from Phase 1b Trial of EDP1815 in Atopic Dermatitis
Back to the Main EVLO Page...